Incidence and Risk of Proteinuria with Aflibercept in Cancer Patients: A Meta-Analysis
Figure 4
Forest plot for meta-analysis of relative risk of all-grade and high-grade proteinuria in cancer patients treated with aflibercept compared with control.
Each study was shown by the name of the lead author and year of publication. Plots are arranged as follows: (A) Relative risk of aflibercept-associated all-grade proteinuria versus control; (B) Relative risk of aflibercept-associated high-grade proteinuria versus control.